Our primary markets include Türkiye, Kazakhstan, Uzbekistan, Kyrgyzstan, Azerbaijan, Russia, Ukraine and Belarus, with plans to expand into additional CIS markets.

Our focus includes Interventional Cardiology, Structural Heart, Peripheral & Endovascular Technologies, Electrophysiology, Cardiac Rhythm Management, Advanced Surgical Technologies and other specialized healthcare technologies.

Yes. We partner with international healthcare technology manufacturers seeking market access, distribution and long-term commercial development across Türkiye and CIS markets.

We provide market assessment, regulatory support, distribution, tender and hospital access, KOL engagement, physician training, product launch support and commercial development.